And while I normally agree with the FDA Law Blog authors on this one, I think what is being overlooked is the compounding pharmacists role in this and how it would interplay with the DQSA and office use that is prohibited. A detailed analysis needs to be done of The Ensuring Safe Access to Prescription Medication Act of 2014 before it is passed especially in light of all the current issues with compounding and compounded pain medications.
Legislation Would End “Constructive Transfer” and Change CSA Definition of “Dispense” to Permit Pharmacy Delivery of Controlled Substances to Physicians for In-Office Administration
Legislation Would End “Constructive Transfer” and Change CSA Definition of “Dispense” to Permit Pharmacy Delivery of Controlled Substances to Physicians for In-Office Administration
No comments:
Post a Comment